Clinical consequences of polypharmacy in elderly

Expert Opinion on Drug Safety

Volumn 13, Issue 1, 2014, Pages 57-65

  Maher, Robert L ^a   Hanlon, Joseph ^b   Hajjar, Emily R ^c  

^a DUQUESNE UNIVERSITY   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Aged; Drug utilization; Polypharmacy; Suboptimal drug use

Indexed keywords

AMLODIPINE; ATENOLOL; ATORVASTATIN; BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIURETIC AGENT; FUROSEMIDE; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROCHLOROTHIAZIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LAXATIVE; LEVOTHYROXINE; LISINOPRIL; METFORMIN; METOPROLOL; OPIATE; SIMVASTATIN; TRICYCLIC ANTIDEPRESSANT AGENT; VITAMIN;

AMBULATORY CARE; COGNITIVE DEFECT; DRUG USE; DRUG UTILIZATION; FALLING; GASTROINTESTINAL DISEASE; GERIATRIC CARE; HOSPITAL CARE; NURSING HOME; PATIENT COMPLIANCE; PHARMACEUTICAL CARE; POLYPHARMACY; REVIEW; URINE INCONTINENCE;

AGE FACTORS; AGED; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; HUMANS; INAPPROPRIATE PRESCRIBING; INTERPROFESSIONAL RELATIONS; NURSING HOMES; PHARMACISTS; PHYSICIAN'S PRACTICE PATTERNS; POLYPHARMACY; PREVALENCE; PROFESSIONAL ROLE;

EID: 84890542268     PISSN: 14740338     EISSN: 1744764X     Source Type: Journal    
DOI: 10.1517/14740338.2013.827660     Document Type: Review

References (57)

1. Merriam Webster Medical Dictionary. Available from: http://www. merriamwebster. com/medlineplus/polypharmacy [Accessed 2 May] [2013]
2. Tjia J, Velten SJ, Parsons C, et al. Studies to reduce unnecessary medication use in frail older adults: a systematic review. Drugs Aging 2013;30:285-307
3. Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother 2007;5:345-51
4. Boyd CM, Darer J, Boult C, et al. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA 2005;294:716-24 (Pubitemid 41159291)
5. Qato DM, Alexander GC, Conti R, et al. Use of prescription and over-The-counter medications and dietary supplements among older adults in the United States. JAMA 2008;300:2867-78
6. Chrischilles EA, Foley DJ, Wallace RB, et al. Use of medications by persons 65 and over: data from the Established Populations for Epidemiologic Studies of the Elderly. J Gerontol Med Sci 1992;47:137-44
7. Rossi MI, Young A, Maher R, et al. Polypharmacy and health beliefs in older outpatients. Am J Geriatr Pharmacother 2007;5:317-23
8. Hajjar E, Hanlon JT, Sloane RJ, et al. Unnecessary drug use in frail older people at hospital discharge. J Am Geriatr Soc 2005;53:1518-23 (Pubitemid 41602441)
9. Nobili A, Licata G, Salerno F, et al. Polypharmacy, length of hospital stay and inpatient mortality among elderly patients in internal medicine wards. The REPOSI study. Eur J Clin Pharmacol 2011;67:507-19
10. Dwyer L, Han B, Woodwell D, et al. Polypharmacy in nursing home residents in the United States: results of the 2004 National Nursing Home Survey. Am J Geriatr Pharmacother 2009;8:63-72
11. Bronskill S, Sudeep S, Gill MD, et al. Exploring variation in rates of polypharmacy across long term care homes. JAMDA 2012;309:e15-21
12. Akazawa M, Imai H, Igarashi A, Tsutani K. Potentially inappropriate medication use in elderly Japanese patients. Am J Geriatr Pharmacother 2010;8:146-60
13. Hovstadius B, Petersson G. The impact of increasing polypharmacy on prescribed drug expenditure-A register-based study in Sweden 2005-2009. Health Policy 2013;109:166-74
14. Bourgeois FT, Shannon MW, Valim C, et al. Adverse drug events in the outpatient setting: an 11-year national analysis. Pharmacoepidemiol Drug Saf 2010;19:901-10
15. Hohl CM, Dankoff J, Colacone A, et al. Polypharmacy, adverse drug-related events, and potential adverse drug interactions in elderly patients presenting to an emergency department. Ann Emerg Med 2001;38:666-71 (Pubitemid 33131567)
16. Nguyen JK, Fouts MM, Kotabe SE, Lo E. Polypharmacy as a risk factor for adverse drug reactions in geriatric nursing home residents. Am J Geriatr Pharmacother 2006;4:36-41
17. Marcum ZA, Amuan ME, Hanlon JT, et al. Prevalence of unplanned hospitalizations caused by adverse drug reactions in older veterans. J Am Geriatric Soc 2012;60:34-41
18. Gurwitz JH, Field TS, Harrold LR, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 2003;289:1107-16 (Pubitemid 37430324)
19. Mallet L, Spinewine A, Huang A. The challenge of managing drug interactions in elderly people. Lancet 2007;370:185-91 (Pubitemid 47042897)
20. Doan J, Zakrewski-Jakubiak H, Roy J, et al. Prevalence and risk of potential cytochrome p450-mediated drug-drug interactions in older hospitalized patients with polypharmacy. Ann Pharmacother 2013;47:324-32
21. Bjorkman IK, Fastbom J, Schmidt IK, et al. Drug-drug interactions in the elderly. Ann Pharmacother 2002;36:1165-71
22. Juurlink DN, Mamdani M, Kopp A, et al. Drug-drug interactions among elderly patients hospitalized for drug toxicity. JAMA 2003;289:1652-8 (Pubitemid 37430270)
23. Lindblad CI, Artz MB, Pieper CF, et al. Potential drug-disease interactions in frail, hospitalized elderly veterans. Ann Pharmacother 2005;39:412-17 (Pubitemid 40276872)
24. Lindblad CI, Hanlon JT, Gross CR, et al. Clinically important drug- disease interactions and their prevalence in older adults. Clin Ther 2006;28:1133-43 (Pubitemid 44374751)
25. Vik SA, Maxwell CJ, Hogan DB. Measurement, correlates, and health outcomes of medication adherence among seniors. Ann Pharmacother 2004;38:303-12 (Pubitemid 38112246)
26. Lee VW, Pang KK, Hui KC, et al. Medication adherence: is it a hidden drug-related problem in hidden elderly? Geriatr Gerontol Int 2013; [Epub ahead of print]
27. Colley CA, Lucas LM. Polypharmacy: The cure becomes the disease. J Gen Int Med 1993;8:278-83 (Pubitemid 23169392)
28. Salazar JA, Poon I, Nair M. Clinical consequences of polypharmacy in the elderly: expect the unexpected, think the unthinkable. Expert Opin Drug Saf 2007;6:695-704 (Pubitemid 351308281)
29. Rollason V, Vogt N. Reduction of polypharmacy in the elderly: a systematic review of the role of the pharmacist. Drugs Aging 2003;20:817-32 (Pubitemid 37159599)
30. Magaziner J, Cadigan DA, Fedder DO, Hebel JR. Medication use and functional decline among community-dwelling older women. J Aging Health 1989;1:470-84 (Pubitemid 20130393)
31. Crenstil V, Ricks MO, Xue QL, Fried LP. A pharmacoepidemiologic study of community-dwelling, disabled older women: factors associated with medication use. Am J Geriatr Pharmacother 2010;8:215-24
32. Jyrkka J, Enlund H, Lavikainen P, et al. Association of polypharmacy with nutritional status, functional ability and cognitive capacity over a three-year period in an elderly population. Pharmacoepidemiol Drug Saf 2010;20:514-22
33. Rosso AL, Eaton CB, Wallace R, et al. Geriatric syndromes and incident disability in older women: results from the Womens Health Initiative Observational Study. J Am Geriatr Soc 2013;61(3):371-9
34. Stel VS, Smit JH, Plujim SM, Lips P. Consequences of falling in older men and women and risk factors for health service use and functional decline. Age Aging 2004;33:58-65 (Pubitemid 38111450)
35. Martin NJ, Stones MJ, Young JE, et al. Development of delirium: a prospective cohort study in a community hospital. Int Psychogeriatr 2000;12:117-27 (Pubitemid 30180719)
36. Fletcher PC, Berg K, Dalby DM, Hirdes JP. Risk factors for falling among community-based seniors. J Patient Saf 2009;5:61-6
37. Kojima T, Akishita M, Nakamura T, et al. Association of polypharmacy with fall risk among geriatric outpatients. Geriatr Gerontol Int 2011;11:438-44
38. Tromp AM, Plujim SM, Smit JH, et al. Fall-risk screening test: a positive study of predictors for falls in community-dwelling elderly. J Clin Epidemiol 2001;54:837-44 (Pubitemid 32722189)
39. Lee CY, Chen LK, Lo YK, et al. Urinary incontinence: an under-recognized risk factor for falls among elderly dementia patients. Neurourol Urodyn 2011;30:1286-90
40. Damian J, Pastor-Barriuso R, Valderrama-Gama E, de Pedro-Cuesta J. Factors associated with falls among older adults living in institutions. BMC Geriatr 2013;13:6
41. Nuotio M, Jylha M, Luukkaala T, Tammela T. Health problems associated with lower urinary tract symptoms in older women. Scand J Prim Care 2005;23:209-14 (Pubitemid 43378938)
42. Heuberger RA, Caudell K. Polypharmacy and nutritional status in older adults. Drugs Aging 2011;28:315-23
43. Prithviraj GK, Koroukian S, Margevicius S, et al. Patient characteristics associated with polypharmacy and inappropriate prescribing of medications among older adults with cancer. J Geriatr Oncol 2012;3:228-37
44. Bao Y, SHao H, Bishop TF, et al. Inappropriate medication in a national sample of US elderly patients receiving home health care. J Gen Intern Med 2012;27:304-10
45. Cannon KT, Choi MM, Zuniga MA. Potentially inappropriate medication use in patients receiving home health care: a retrospective data analysis. Am J Geriatr Pharmacother 2006;4:134-43 (Pubitemid 44069476)
46. Patterson SM, Hughes C, Kerse N, et al. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev 2012;5:CD008165
47. Schmader KE, Hanlon JT, Pieper CF, et al. Effectiveness of geriatric evaluation and management on adverse drug reactions and suboptimal prescribing in the frail elderly. Am J Med 2004;116:394-401 (Pubitemid 38299484)
48. Spinewine A, Swine C, Dhillon S, et al. Effect of a collaborative approach on the quality of prescribing for geriatric inpatients: a randomized, controlled trial. J Am Geriatr Soc 2007;55:658-65 (Pubitemid 46668957)
49. Hanlon JT, Weinberger M, Samsa GP, et al. A randomized controlled trial of a clinical pharmacist intervention with elderly outpatients with polypharmacy. Am J Med 1996;100:428-3
50. Gallagher PF, OConnor MN, OMahony D. Prevention of potentially inappropriate prescribing for elderly patients: a randomized controlled trial using STOPP/START Criteria. Clin Pharmacol Ther 2011;89:845-54
51. Bregnhoj L, Thirstrup S, Kristensen MB, et al. Combined intervention programme reduces inappropriate prescribing in elderly patients exposed to polypharmacy in primary care. Eur J Clin Pharmacol 2009;65:199-207
52. Lipton HL, Bero LA, Bird JA, McPhee SJ. The impact of clinical pharmacists consultations on physicians geriatric drug prescribing. A randomized controlled trial. Med Care 1992;30:646-58
53. Owens NJ, Sherburne NJ, Silliman RA, Fretwell MD. The Senior Care Study : The optimal use of medications in acutely ill older patients. J Am Geriatr Soc 1990;38:1082-7
54. Krska J, Cromarty JA, Arris F, et al. Pharmacist-led medication review in patients over 65: a randomized, controlled trial in primary care. Age Ageing 2001;30:205-11 (Pubitemid 32684900)
55. Hellstrom LM, Bondesson A, Hoglund P, et al. Impact of the Lund Integrated Medicines Management (LIMM) model on medication appropriateness and drug-related hospital revisits. Eur J Clin Pharmacol 2011;67:741-52
56. Crotty M, Rowett D, Spurling L, et al. Does the addition of a pharmacist transition coordinator improve evidence-based medication management and health outcomes in older adults moving from the hospital to a long-Term care facility? results of a randomized, controlled trial. Am J Geriatr Pharmacother 2004;2:257-64 (Pubitemid 40378780)
57. Pellegrino AN, Martin MT, Tilton JJ, et al. Medication therapy management services. Drugs 2009;69(4):393-406